LabCompass

Publications

412

Citations

17,071

Est. group size

Recurring co-author estimate

Active years

33

Publishing since 1994

Research summary
AI-generated

This researcher works on gene therapy, focusing on using engineered viruses (such as adeno-associated viruses, or AAV) to deliver therapeutic genes for inherited diseases like hemophilia and Duchenne muscular dystrophy. A major theme is understanding and controlling the body's immune responses to these gene-delivery vectors, including strategies to induce immune tolerance and improve safety and effectiveness of treatment.

Viral gene therapy (AAV vectors)Immune tolerance and immunosuppression in gene deliveryDuchenne muscular dystrophy treatmentHemophilia gene therapyInnate immune sensing of therapeutic vectors

Publication activity has been consistently high over the past decade, averaging around 20+ papers per year, with some year-to-year fluctuation.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 21.4/year recently
2017: 21 publications172018: 12 publications182019: 18 publications192020: 35 publications202021: 20 publications212022: 24 publications222023: 36 publications36232024: 24 publications242025: 15 publications252026: 8 publications26
Recent publications
Publishes in
  • Molecular Therapy×61
  • Blood×21
  • arXiv (Cornell University)×21
  • Molecular Therapy — Methods & Clinical Development×14
  • Frontiers in Immunology×7

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile